بسم الله الرحمن الرحيم سبب الإرتفاع هو موافقة شركة abt على شراء شركة kosp بقيمة 78 دولارا للسهم الواحد. قد لا يتجاوز سعره المبلغ المذكور.
KOS Pharma to be acquired by ABT for $78 per share in cash (50.09 ) -Update : Abbott (ABT) and KOSP announced Abbott will acquire KOSP for $78 per share in cash, for a total transaction value of $3.7 bln, net of cash currently held by KOSP. Abbott expects the transaction to be $0.02 to $0.03 dilutive to ongoing earnings per share in 2007, neutral to accretive in 2008 and building to significant accretion thereafter. Following the closing, the transaction is expected to result in one-time charges, primarily for in-process research and development and integration expenses.
